APO Research
Talk to an analyst

APO RESEARCH · REPORT

Crohn’s Disease Treatment

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Crohn’s Disease Treatment Market Analysis and Forecast 2026-2032

21 December 2025199 pages

Choose your research edition.

Industry ResearchCrohn’s Disease Treatment Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Crohn’s Disease Treatment Industry Growth and Trends Forecast to 2032104 pages · $3,450 USDMarket StructureGlobal Crohn’s Disease Treatment Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Crohn’s Disease Treatment Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Crohn’s Disease Treatment Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Crohn’s Disease Treatment market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Crohn’s Disease Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Crohn’s Disease Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Crohn’s Disease Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Crohn’s Disease Treatment is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Crohn’s Disease Treatment include Takeda Pharmaceutical Ltd, Johnson & Johnson, Roche, Pfizer Inc., Biogen, Bristol Myers Squibb, Abbvie Inc., AstraZeneca and Prometheus Laboratories Inc. (Nestle), etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Crohn’s Disease Treatment, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Crohn’s Disease Treatment, also provides the revenue of main regions and countries. Of the upcoming market potential for Crohn’s Disease Treatment, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Crohn’s Disease Treatment revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Crohn’s Disease Treatment market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Crohn’s Disease Treatment revenue, projected growth trends, production technology, application and end-user industry.

Crohn’s Disease Treatment Segment by Company

Takeda Pharmaceutical Ltd

Johnson & Johnson

Roche

Pfizer Inc.

Biogen

Bristol Myers Squibb

Abbvie Inc.

AstraZeneca

Prometheus Laboratories Inc. (Nestle)

Bausch Health

Crohn’s Disease Treatment Segment by Type

Corticosteroids

Immunomodulators

Antibiotics

Amino Salicylates

Others

Crohn’s Disease Treatment Segment by Application

Hospitals

Specialty Clinics

Other

Crohn’s Disease Treatment Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Crohn’s Disease Treatment market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Crohn’s Disease Treatment and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Crohn’s Disease Treatment.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Crohn’s Disease Treatment in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Crohn’s Disease Treatment company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Crohn’s Disease Treatment revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Crohn’s Disease Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Corticosteroids Major Player Table 3. Immunomodulators Major Player Table 4. Antibiotics Major Player Table 5. Amino Salicylates Major Player Table 6. Others Major Player Table 7. Global Crohn’s Disease Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Hospitals Major Player Table 9. Specialty Clinics Major Player Table 10. Other Major Player Table 11. Crohn’s Disease Treatment Industry Trends Table 12. Crohn’s Disease Treatment Industry Drivers Table 13. Crohn’s Disease Treatment Industry Opportunities and Challenges Table 14. Crohn’s Disease Treatment Industry Restraints Table 15. Global Crohn’s Disease Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 16. Global Crohn’s Disease Treatment Market Size by Region (2021-2026) & (US$ Million) Table 17. Global Crohn’s Disease Treatment Market Share by Region (2021-2026) Table 18. Global Crohn’s Disease Treatment Market Size by Region (2027-2032) & (US$ Million) Table 19. Global Crohn’s Disease Treatment Market Share by Region (2027-2032) Table 20. Global Crohn’s Disease Treatment Revenue by Players (US$ Million) & (2021-2026) Table 21. Global Crohn’s Disease Treatment Revenue Market Share by Players (2021-2026) Table 22. Global Crohn’s Disease Treatment Key Players Ranking, 2024 VS 2025 VS 2026 Table 23. Global Crohn’s Disease Treatment Key Players Headquarters & Area Served Table 24. Global Crohn’s Disease Treatment Players, Product Type & Application Table 25. Global Crohn’s Disease Treatment Players Establishment Date Table 26. Global Players Market Concentration Ratio (CR5 and HHI) Table 27. Global Crohn’s Disease Treatment by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 28. Global Crohn’s Disease Treatment Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Crohn’s Disease Treatment Revenue by Type (2021-2026) & (US$ Million) Table 30. Global Crohn’s Disease Treatment Revenue by Type (2027-2032) & (US$ Million) Table 31. Global Crohn’s Disease Treatment Revenue Market Share by Type (2021-2026) Table 32. Global Crohn’s Disease Treatment Revenue Market Share by Type (2027-2032) Table 33. Global Crohn’s Disease Treatment Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Crohn’s Disease Treatment Revenue by Application (2021-2026) & (US$ Million) Table 35. Global Crohn’s Disease Treatment Revenue by Application (2027-2032) & (US$ Million) Table 36. Global Crohn’s Disease Treatment Revenue Market Share by Application (2021-2026) Table 37. Global Crohn’s Disease Treatment Revenue Market Share by Application (2027-2032) Table 38. Takeda Pharmaceutical Ltd Company Information Table 39. Takeda Pharmaceutical Ltd Business Overview Table 40. Takeda Pharmaceutical Ltd Crohn’s Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 41. Takeda Pharmaceutical Ltd Crohn’s Disease Treatment Product Portfolio Table 42. Takeda Pharmaceutical Ltd Recent Development Table 43. Johnson & Johnson Company Information Table 44. Johnson & Johnson Business Overview Table 45. Johnson & Johnson Crohn’s Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 46. Johnson & Johnson Crohn’s Disease Treatment Product Portfolio Table 47. Johnson & Johnson Recent Development Table 48. Roche Company Information Table 49. Roche Business Overview Table 50. Roche Crohn’s Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 51. Roche Crohn’s Disease Treatment Product Portfolio Table 52. Roche Recent Development Table 53. Pfizer Inc. Company Information Table 54. Pfizer Inc. Business Overview Table 55. Pfizer Inc. Crohn’s Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 56. Pfizer Inc. Crohn’s Disease Treatment Product Portfolio Table 57. Pfizer Inc. Recent Development Table 58. Biogen Company Information Table 59. Biogen Business Overview Table 60. Biogen Crohn’s Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 61. Biogen Crohn’s Disease Treatment Product Portfolio Table 62. Biogen Recent Development Table 63. Bristol Myers Squibb Company Information Table 64. Bristol Myers Squibb Business Overview Table 65. Bristol Myers Squibb Crohn’s Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 66. Bristol Myers Squibb Crohn’s Disease Treatment Product Portfolio Table 67. Bristol Myers Squibb Recent Development Table 68. Abbvie Inc. Company Information Table 69. Abbvie Inc. Business Overview Table 70. Abbvie Inc. Crohn’s Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 71. Abbvie Inc. Crohn’s Disease Treatment Product Portfolio Table 72. Abbvie Inc. Recent Development Table 73. AstraZeneca Company Information Table 74. AstraZeneca Business Overview Table 75. AstraZeneca Crohn’s Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 76. AstraZeneca Crohn’s Disease Treatment Product Portfolio Table 77. AstraZeneca Recent Development Table 78. Prometheus Laboratories Inc. (Nestle) Company Information Table 79. Prometheus Laboratories Inc. (Nestle) Business Overview Table 80. Prometheus Laboratories Inc. (Nestle) Crohn’s Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 81. Prometheus Laboratories Inc. (Nestle) Crohn’s Disease Treatment Product Portfolio Table 82. Prometheus Laboratories Inc. (Nestle) Recent Development Table 83. Bausch Health Company Information Table 84. Bausch Health Business Overview Table 85. Bausch Health Crohn’s Disease Treatment Revenue and Gross Margin (US$ Million) & (2021-2026) Table 86. Bausch Health Crohn’s Disease Treatment Product Portfolio Table 87. Bausch Health Recent Development Table 88. North America Crohn’s Disease Treatment Revenue by Type (2021-2026) & (US$ Million) Table 89. North America Crohn’s Disease Treatment Revenue by Type (2027-2032) & (US$ Million) Table 90. North America Crohn’s Disease Treatment Revenue by Application (2021-2026) & (US$ Million) Table 91. North America Crohn’s Disease Treatment Revenue by Application (2027-2032) & (US$ Million) Table 92. North America Crohn’s Disease Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 93. North America Crohn’s Disease Treatment Revenue by Country (2021-2026) & (US$ Million) Table 94. North America Crohn’s Disease Treatment Revenue by Country (US$ Million) & (2027-2032) Table 95. Europe Crohn’s Disease Treatment Revenue by Type (2021-2026) & (US$ Million) Table 96. Europe Crohn’s Disease Treatment Revenue by Type (2027-2032) & (US$ Million) Table 97. Europe Crohn’s Disease Treatment Revenue by Application (2021-2026) & (US$ Million) Table 98. Europe Crohn’s Disease Treatment Revenue by Application (2027-2032) & (US$ Million) Table 99. Europe Crohn’s Disease Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 100. Europe Crohn’s Disease Treatment Revenue by Country (2021-2026) & (US$ Million) Table 101. Europe Crohn’s Disease Treatment Revenue by Country (US$ Million) & (2027-2032) Table 102. China Crohn’s Disease Treatment Revenue by Type (2021-2026) & (US$ Million) Table 103. China Crohn’s Disease Treatment Revenue by Type (2027-2032) & (US$ Million) Table 104. China Crohn’s Disease Treatment Revenue by Application (2021-2026) & (US$ Million) Table 105. China Crohn’s Disease Treatment Revenue by Application (2027-2032) & (US$ Million) Table 106. Asia Crohn’s Disease Treatment Revenue by Type (2021-2026) & (US$ Million) Table 107. Asia Crohn’s Disease Treatment Revenue by Type (2027-2032) & (US$ Million) Table 108. Asia Crohn’s Disease Treatment Revenue by Application (2021-2026) & (US$ Million) Table 109. Asia Crohn’s Disease Treatment Revenue by Application (2027-2032) & (US$ Million) Table 110. Asia Crohn’s Disease Treatment Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 111. Asia Crohn’s Disease Treatment Revenue by Region (US$ Million) & (2021-2026) Table 112. Asia Crohn’s Disease Treatment Revenue by Region (US$ Million) & (2027-2032) Table 113. SAMEA Crohn’s Disease Treatment Revenue by Type (2021-2026) & (US$ Million) Table 114. SAMEA Crohn’s Disease Treatment Revenue by Type (2027-2032) & (US$ Million) Table 115. SAMEA Crohn’s Disease Treatment Revenue by Application (2021-2026) & (US$ Million) Table 116. SAMEA Crohn’s Disease Treatment Revenue by Application (2027-2032) & (US$ Million) Table 117. SAMEA Crohn’s Disease Treatment Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 118. SAMEA Crohn’s Disease Treatment Revenue by Country (2021-2026) & (US$ Million) Table 119. SAMEA Crohn’s Disease Treatment Revenue by Country (US$ Million) & (2027-2032) Table 120. Research Programs/Design for This Report Table 121. Authors List of This Report Table 122. Secondary Sources Table 123. Primary Sources List of Figures Figure 1. Crohn’s Disease Treatment Image Figure 2. Global Crohn’s Disease Treatment Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Crohn’s Disease Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 4. Corticosteroids Image Figure 5. Immunomodulators Image Figure 6. Antibiotics Image Figure 7. Amino Salicylates Image Figure 8. Others Image Figure 9. Global Crohn’s Disease Treatment Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Crohn’s Disease Treatment Market Size Share 2021 VS 2025 VS 2032 Figure 11. Hospitals Image Figure 12. Specialty Clinics Image Figure 13. Other Image Figure 14. Global Crohn’s Disease Treatment Market Size (US$ Million) & (2021-2032) Figure 15. Global Crohn’s Disease Treatment Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Crohn’s Disease Treatment Market Share by Region: 2021 VS 2025 VS 2032 Figure 17. Global Crohn’s Disease Treatment Players Revenue Share Top 10 and Top 5 in 2025 Figure 18. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 19. Global Crohn’s Disease Treatment Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 20. Global Crohn’s Disease Treatment Revenue Market Share 2021 VS 2025 VS 2032 Figure 21. Global Crohn’s Disease Treatment Revenue Market Share by Type (2021-2032) Figure 22. Global Crohn’s Disease Treatment Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global Crohn’s Disease Treatment Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 24. Global Crohn’s Disease Treatment Revenue Market Share by Application (2021-2032) Figure 25. North America Crohn’s Disease Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 26. North America Crohn’s Disease Treatment Revenue Share by Type (2021-2032) Figure 27. North America Crohn’s Disease Treatment Revenue Share by Application (2021-2032) Figure 28. North America Crohn’s Disease Treatment Revenue Share by Country (2021-2032) Figure 29. United States Crohn’s Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Canada Crohn’s Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Mexico Crohn’s Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 32. Europe Crohn’s Disease Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 33. Europe Crohn’s Disease Treatment Revenue Share by Type (2021-2032) Figure 34. Europe Crohn’s Disease Treatment Revenue Share by Application (2021-2032) Figure 35. Europe Crohn’s Disease Treatment Revenue Share by Country (2021-2032) Figure 36. Germany Crohn’s Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. France Crohn’s Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. U.K. Crohn’s Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Italy Crohn’s Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Spain Crohn’s Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Russia Crohn’s Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Netherlands Crohn’s Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. Nordic Countries Crohn’s Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 44. China Crohn’s Disease Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 45. China Crohn’s Disease Treatment Revenue Share by Type (2021-2032) Figure 46. China Crohn’s Disease Treatment Revenue Share by Application (2021-2032) Figure 47. Asia Crohn’s Disease Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 48. Asia Crohn’s Disease Treatment Revenue Share by Type (2021-2032) Figure 49. Asia Crohn’s Disease Treatment Revenue Share by Application (2021-2032) Figure 50. Asia Crohn’s Disease Treatment Revenue Share by Region (2021-2032) Figure 51. Japan Crohn’s Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. South Korea Crohn’s Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. India Crohn’s Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Australia Crohn’s Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Taiwan Crohn’s Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. Southeast Asia Crohn’s Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 57. SAMEA Crohn’s Disease Treatment Revenue YoY Growth (2021-2032) & (US$ Million) Figure 58. SAMEA Crohn’s Disease Treatment Revenue Share by Type (2021-2032) Figure 59. SAMEA Crohn’s Disease Treatment Revenue Share by Application (2021-2032) Figure 60. SAMEA Crohn’s Disease Treatment Revenue Share by Country (2021-2032) Figure 61. Brazil Crohn’s Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Argentina Crohn’s Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Chile Crohn’s Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Colombia Crohn’s Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Peru Crohn’s Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Saudi Arabia Crohn’s Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. Israel Crohn’s Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. UAE Crohn’s Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Turkey Crohn’s Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Iran Crohn’s Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Egypt Crohn’s Disease Treatment Revenue YoY Growth (US$ Million) & (2021-2032) Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Corticosteroids
  • Immunomodulators
  • Antibiotics
  • Amino Salicylates
  • Others
Applications
  • Hospitals
  • Specialty Clinics
  • Other
Companies covered
  • Takeda Pharmaceutical Ltd
  • Johnson & Johnson
  • Roche
  • Pfizer Inc.
  • Biogen
  • Bristol Myers Squibb
  • Abbvie Inc.
  • AstraZeneca
  • Prometheus Laboratories Inc. (Nestle)
  • Bausch Health

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Crohn’s Disease Treatment Market by Type
  3. 1.2.1 Global Crohn’s Disease Treatment Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Corticosteroids
  5. 1.2.3 Immunomodulators
  6. 1.2.4 Antibiotics
  7. 1.2.5 Amino Salicylates
  8. 1.2.6 Others
  9. 1.3 Crohn’s Disease Treatment Market by Application
  10. 1.3.1 Global Crohn’s Disease Treatment Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Hospitals
  12. 1.3.3 Specialty Clinics
  13. 1.3.4 Other
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Crohn’s Disease Treatment Market Dynamics
  1. 2.1 Crohn’s Disease Treatment Industry Trends
  2. 2.2 Crohn’s Disease Treatment Industry Drivers
  3. 2.3 Crohn’s Disease Treatment Industry Opportunities and Challenges
  4. 2.4 Crohn’s Disease Treatment Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Crohn’s Disease Treatment Market Perspective (2021-2032)
  2. 3.2 Global Crohn’s Disease Treatment Growth Trends by Region
  3. 3.2.1 Global Crohn’s Disease Treatment Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Crohn’s Disease Treatment Market Size by Region (2021-2026)
  5. 3.2.3 Global Crohn’s Disease Treatment Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Crohn’s Disease Treatment Revenue by Players
  2. 4.1.1 Global Crohn’s Disease Treatment Revenue by Players (2021-2026)
  3. 4.1.2 Global Crohn’s Disease Treatment Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Crohn’s Disease Treatment Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Crohn’s Disease Treatment Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Crohn’s Disease Treatment Key Players Headquarters & Area Served
  7. 4.4 Global Crohn’s Disease Treatment Players, Product Type & Application
  8. 4.5 Global Crohn’s Disease Treatment Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Crohn’s Disease Treatment Market CR5 and HHI
  11. 4.6.3 2025 Crohn’s Disease Treatment Tier 1, Tier 2, and Tier 3
5 Crohn’s Disease Treatment Market Size by Type
  1. 5.1 Global Crohn’s Disease Treatment Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Crohn’s Disease Treatment Revenue by Type (2021-2032)
  3. 5.3 Global Crohn’s Disease Treatment Revenue Market Share by Type (2021-2032)
6 Crohn’s Disease Treatment Market Size by Application
  1. 6.1 Global Crohn’s Disease Treatment Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Crohn’s Disease Treatment Revenue by Application (2021-2032)
  3. 6.3 Global Crohn’s Disease Treatment Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 Takeda Pharmaceutical Ltd
  2. 7.1.1 Takeda Pharmaceutical Ltd Company Information
  3. 7.1.2 Takeda Pharmaceutical Ltd Business Overview
  4. 7.1.3 Takeda Pharmaceutical Ltd Crohn’s Disease Treatment Revenue and Gross Margin (2021-2026)
  5. 7.1.4 Takeda Pharmaceutical Ltd Crohn’s Disease Treatment Product Portfolio
  6. 7.1.5 Takeda Pharmaceutical Ltd Recent Developments
  7. 7.2 Johnson & Johnson
  8. 7.2.1 Johnson & Johnson Company Information
  9. 7.2.2 Johnson & Johnson Business Overview
  10. 7.2.3 Johnson & Johnson Crohn’s Disease Treatment Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Johnson & Johnson Crohn’s Disease Treatment Product Portfolio
  12. 7.2.5 Johnson & Johnson Recent Developments
  13. 7.3 Roche
  14. 7.3.1 Roche Company Information
  15. 7.3.2 Roche Business Overview
  16. 7.3.3 Roche Crohn’s Disease Treatment Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Roche Crohn’s Disease Treatment Product Portfolio
  18. 7.3.5 Roche Recent Developments
  19. 7.4 Pfizer Inc.
  20. 7.4.1 Pfizer Inc. Company Information
  21. 7.4.2 Pfizer Inc. Business Overview
  22. 7.4.3 Pfizer Inc. Crohn’s Disease Treatment Revenue and Gross Margin (2021-2026)
  23. 7.4.4 Pfizer Inc. Crohn’s Disease Treatment Product Portfolio
  24. 7.4.5 Pfizer Inc. Recent Developments
  25. 7.5 Biogen
  26. 7.5.1 Biogen Company Information
  27. 7.5.2 Biogen Business Overview
  28. 7.5.3 Biogen Crohn’s Disease Treatment Revenue and Gross Margin (2021-2026)
  29. 7.5.4 Biogen Crohn’s Disease Treatment Product Portfolio
  30. 7.5.5 Biogen Recent Developments
  31. 7.6 Bristol Myers Squibb
  32. 7.6.1 Bristol Myers Squibb Company Information
  33. 7.6.2 Bristol Myers Squibb Business Overview
  34. 7.6.3 Bristol Myers Squibb Crohn’s Disease Treatment Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Bristol Myers Squibb Crohn’s Disease Treatment Product Portfolio
  36. 7.6.5 Bristol Myers Squibb Recent Developments
  37. 7.7 Abbvie Inc.
  38. 7.7.1 Abbvie Inc. Company Information
  39. 7.7.2 Abbvie Inc. Business Overview
  40. 7.7.3 Abbvie Inc. Crohn’s Disease Treatment Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Abbvie Inc. Crohn’s Disease Treatment Product Portfolio
  42. 7.7.5 Abbvie Inc. Recent Developments
  43. 7.8 AstraZeneca
  44. 7.8.1 AstraZeneca Company Information
  45. 7.8.2 AstraZeneca Business Overview
  46. 7.8.3 AstraZeneca Crohn’s Disease Treatment Revenue and Gross Margin (2021-2026)
  47. 7.8.4 AstraZeneca Crohn’s Disease Treatment Product Portfolio
  48. 7.8.5 AstraZeneca Recent Developments
  49. 7.9 Prometheus Laboratories Inc. (Nestle)
  50. 7.9.1 Prometheus Laboratories Inc. (Nestle) Company Information
  51. 7.9.2 Prometheus Laboratories Inc. (Nestle) Business Overview
  52. 7.9.3 Prometheus Laboratories Inc. (Nestle) Crohn’s Disease Treatment Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Prometheus Laboratories Inc. (Nestle) Crohn’s Disease Treatment Product Portfolio
  54. 7.9.5 Prometheus Laboratories Inc. (Nestle) Recent Developments
  55. 7.10 Bausch Health
  56. 7.10.1 Bausch Health Company Information
  57. 7.10.2 Bausch Health Business Overview
  58. 7.10.3 Bausch Health Crohn’s Disease Treatment Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Bausch Health Crohn’s Disease Treatment Product Portfolio
  60. 7.10.5 Bausch Health Recent Developments
8 North America
  1. 8.1 North America Crohn’s Disease Treatment Revenue (2021-2032)
  2. 8.2 North America Crohn’s Disease Treatment Revenue by Type (2021-2032)
  3. 8.2.1 North America Crohn’s Disease Treatment Revenue by Type (2021-2026)
  4. 8.2.2 North America Crohn’s Disease Treatment Revenue by Type (2027-2032)
  5. 8.3 North America Crohn’s Disease Treatment Revenue Share by Type (2021-2032)
  6. 8.4 North America Crohn’s Disease Treatment Revenue by Application (2021-2032)
  7. 8.4.1 North America Crohn’s Disease Treatment Revenue by Application (2021-2026)
  8. 8.4.2 North America Crohn’s Disease Treatment Revenue by Application (2027-2032)
  9. 8.5 North America Crohn’s Disease Treatment Revenue Share by Application (2021-2032)
  10. 8.6 North America Crohn’s Disease Treatment Revenue by Country
  11. 8.6.1 North America Crohn’s Disease Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Crohn’s Disease Treatment Revenue by Country (2021-2026)
  13. 8.6.3 North America Crohn’s Disease Treatment Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Crohn’s Disease Treatment Revenue (2021-2032)
  2. 9.2 Europe Crohn’s Disease Treatment Revenue by Type (2021-2032)
  3. 9.2.1 Europe Crohn’s Disease Treatment Revenue by Type (2021-2026)
  4. 9.2.2 Europe Crohn’s Disease Treatment Revenue by Type (2027-2032)
  5. 9.3 Europe Crohn’s Disease Treatment Revenue Share by Type (2021-2032)
  6. 9.4 Europe Crohn’s Disease Treatment Revenue by Application (2021-2032)
  7. 9.4.1 Europe Crohn’s Disease Treatment Revenue by Application (2021-2026)
  8. 9.4.2 Europe Crohn’s Disease Treatment Revenue by Application (2027-2032)
  9. 9.5 Europe Crohn’s Disease Treatment Revenue Share by Application (2021-2032)
  10. 9.6 Europe Crohn’s Disease Treatment Revenue by Country
  11. 9.6.1 Europe Crohn’s Disease Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Crohn’s Disease Treatment Revenue by Country (2021-2026)
  13. 9.6.3 Europe Crohn’s Disease Treatment Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Crohn’s Disease Treatment Revenue (2021-2032)
  2. 10.2 China Crohn’s Disease Treatment Revenue by Type (2021-2032)
  3. 10.2.1 China Crohn’s Disease Treatment Revenue by Type (2021-2026)
  4. 10.2.2 China Crohn’s Disease Treatment Revenue by Type (2027-2032)
  5. 10.3 China Crohn’s Disease Treatment Revenue Share by Type (2021-2032)
  6. 10.4 China Crohn’s Disease Treatment Revenue by Application (2021-2032)
  7. 10.4.1 China Crohn’s Disease Treatment Revenue by Application (2021-2026)
  8. 10.4.2 China Crohn’s Disease Treatment Revenue by Application (2027-2032)
  9. 10.5 China Crohn’s Disease Treatment Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Crohn’s Disease Treatment Revenue (2021-2032)
  2. 11.2 Asia Crohn’s Disease Treatment Revenue by Type (2021-2032)
  3. 11.2.1 Asia Crohn’s Disease Treatment Revenue by Type (2021-2026)
  4. 11.2.2 Asia Crohn’s Disease Treatment Revenue by Type (2027-2032)
  5. 11.3 Asia Crohn’s Disease Treatment Revenue Share by Type (2021-2032)
  6. 11.4 Asia Crohn’s Disease Treatment Revenue by Application (2021-2032)
  7. 11.4.1 Asia Crohn’s Disease Treatment Revenue by Application (2021-2026)
  8. 11.4.2 Asia Crohn’s Disease Treatment Revenue by Application (2027-2032)
  9. 11.5 Asia Crohn’s Disease Treatment Revenue Share by Application (2021-2032)
  10. 11.6 Asia Crohn’s Disease Treatment Revenue by Country
  11. 11.6.1 Asia Crohn’s Disease Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Crohn’s Disease Treatment Revenue by Country (2021-2026)
  13. 11.6.3 Asia Crohn’s Disease Treatment Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Crohn’s Disease Treatment Revenue (2021-2032)
  2. 12.2 SAMEA Crohn’s Disease Treatment Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Crohn’s Disease Treatment Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Crohn’s Disease Treatment Revenue by Type (2027-2032)
  5. 12.3 SAMEA Crohn’s Disease Treatment Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Crohn’s Disease Treatment Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Crohn’s Disease Treatment Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Crohn’s Disease Treatment Revenue by Application (2027-2032)
  9. 12.5 SAMEA Crohn’s Disease Treatment Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Crohn’s Disease Treatment Revenue by Country
  11. 12.6.1 SAMEA Crohn’s Disease Treatment Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Crohn’s Disease Treatment Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Crohn’s Disease Treatment Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst